ObsEva SA OBSEF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 117.18M
- Market Cap
- $117.18
- Volume/Avg
- 950 / 8,440
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.obseva.com
Valuation
Metric | OBSEF |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | OBSEF |
|---|---|
Quick Ratio | 1.21 |
Current Ratio | 2.23 |
Interest Coverage | −2.24 |
Quick Ratio
OBSEF
Profitability
Metric | OBSEF |
|---|---|
Return on Assets (Normalized) | −41.53% |
Return on Equity (Normalized) | −227.14% |
Return on Invested Capital (Normalized) | −41.89% |
Return on Assets
OBSEF
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|gyXw?$R | LOCK|$^fF | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|#$$jM>h | LOCK|dfS!K | $95B | |||
| Moderna Inc MRNA | LOCK|Cr$w<C | LOCK|!$ | $79B | |||
| argenx SE ADR ARGX | LOCK|CGk^jd? | LOCK|%@ | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|n#vSBVR | LOCK|>Z | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|xl^VdH%X | LOCK|@k$& | $30B | |||
| Incyte Corp INCY | LOCK|%FSLhq! | LOCK|V^F | $23B | |||
| BioNTech SE ADR BNTX | LOCK|kg$wnww | LOCK|G< | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|%L$$y> | LOCK|R@wFQ | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|J@C<>F< | LOCK|#! | $15B |